Smoking Addiction: Neurobiology, Behavioral Patterns, and Cessation Strategies
Tobacco use disorder (DSM-5) = chronic, relapsing condition driven by nicotine's neuropharmacology and learned behaviors.
Neurobiology
- Nicotine → α4β2 nicotinic ACh receptors → dopamine release in nucleus accumbens (reward)
- Chronic exposure → upregulation, desensitization → tolerance, withdrawal
- Cue-conditioning: contexts (coffee, break, alcohol) trigger craving via glutamate/dopamine
Dependence Dimensions
- Physical: Withdrawal (irritability, anxiety, insomnia, concentration difficulty, hunger) peaks 2–3 days, lasts weeks
- Psychological: Stress coping, identity, social ritual
- Behavioral: Automaticity, cue-triggered
Evidence-Based Cessation
- Combined pharmacotherapy + counseling = highest success
- Meds: Varenicline (Chantix) > combination NRT > bupropion > single NRT
- NRT: Patch + short-acting (gum/lozenge/inhaler) — 8–12 weeks
- Counseling: CBT, motivational interviewing, quitlines (1-800-QUIT-NOW)
- Relapse prevention: Identify triggers, coping skills, slip ≠ failure
Population-Specific
Pregnancy: NRT preferred; behavioral first. Mental illness: integrated treatment. Youth: counseling + NRT (off-label).
Most smokers require multiple attempts. Each attempt builds skills.
Drug Addiction - Related Articles
- Recognizing Opiate Use: Signs, Risks & Addiction
- Liver as the Body's Alcohol Detox Center: How It Works
- Alcohol Withdrawal Medications: A Comprehensive Overview
- Hypnotherapy for Smoking Cessation: A Powerful Solution
- Understanding Federal Laws for Methadone Treatment
- Alcohol Disrupts Short‑Term Memory: Mechanism and Dose‑Response Evidence
- Overcoming Drug Addiction: Understanding the Challenges & Finding Support
